Index -
P/E -
EPS (ttm) -0.25
Insider Own 55.98%
Shs Outstand 13.56M
Perf Week -1.05%
Market Cap 64.14M
Forward P/E 24.84
EPS next Y 0.19
Insider Trans 0.00%
Shs Float 5.98M
Perf Month -0.42%
Income -3.40M
PEG -
EPS next Q 0.01
Inst Own 20.10%
Short Float 5.48%
Perf Quarter -4.45%
Sales 51.65M
P/S 1.24
EPS this Y 128.26%
Inst Trans -0.67%
Short Ratio 6.36
Perf Half Y -9.58%
Book/sh -0.02
P/B -
EPS next Y 46.15%
ROA -12.39%
Short Interest 0.33M
Perf Year -28.16%
Cash/sh 0.21
P/C 22.20
EPS next 5Y 15.00%
ROE -432.46%
52W Range 3.60 - 7.13
Perf YTD -16.01%
Dividend Est. -
P/FCF -
EPS past 5Y -
ROI -60.79%
52W High -33.80%
Beta 0.46
Dividend TTM -
Quick Ratio 0.69
Sales past 5Y 13.78%
Gross Margin 44.27%
52W Low 31.11%
ATR (14) 0.40
Dividend Ex-Date -
Current Ratio 0.69
EPS Y/Y TTM 55.19%
Oper. Margin -5.88%
RSI (14) 52.45
Volatility 7.66% 9.61%
Employees 210
Debt/Eq -
Sales Y/Y TTM -1.96%
Profit Margin -6.58%
Recom 1.00
Target Price 6.00
Option/Short Yes / Yes
LT Debt/Eq -
EPS Q/Q 149.21%
Payout -
Rel Volume 0.80
Prev Close 4.81
Sales Surprise 6.60%
EPS Surprise 466.67%
Sales Q/Q 11.94%
Earnings Sep 11 AMC
Avg Volume 51.52K
Price 4.72
SMA20 5.20%
SMA50 1.94%
SMA200 -7.93%
Trades
Volume 41,407
Change -1.87%
Date
Action
Analyst
Rating Change
Price Target Change
Sep-12-24 Upgrade
Craig Hallum
Hold → Buy
$6
Nov-18-19 Initiated
The Benchmark Company
Speculative Buy
Sep-12-24 08:03AM
Sep-11-24 04:00PM
Sep-09-24 04:00PM
Jul-18-24 09:53PM
04:00PM
04:05PM
Loading…
Jul-11-24 04:05PM
Jun-04-24 09:00AM
Mar-19-24 08:28AM
Mar-12-24 04:30PM
Mar-07-24 09:00AM
Mar-06-24 04:35PM
Dec-14-23 08:22AM
Dec-12-23 09:54PM
(InvestorPlace) -6.49%
+5.42%
04:00PM
Dec-04-23 04:30PM
08:30AM
Loading…
Nov-02-23 08:30AM
Oct-17-23 08:30AM
Sep-13-23 04:00PM
Sep-11-23 04:00PM
Aug-22-23 08:30AM
Aug-01-23 08:45AM
Jul-24-23 04:00PM
Jul-20-23 04:00PM
Apr-17-23 08:30AM
Apr-05-23 09:50AM
Mar-15-23 03:50PM
Mar-13-23 08:30AM
Dec-16-22 08:48AM
Dec-13-22 04:00PM
(ACCESSWIRE) +5.21%
-31.04%
Dec-09-22 04:30PM
04:00PM
Loading…
Sep-08-22 04:00PM
Sep-06-22 04:00PM
Aug-15-22 08:08AM
Jul-23-22 09:57AM
Jul-21-22 04:00PM
Jul-14-22 04:00PM
Jun-13-22 06:30AM
May-31-22 08:30AM
May-03-22 08:30AM
May-02-22 01:16PM
Mar-15-22 04:45PM
Mar-11-22 08:30AM
Mar-07-22 01:10PM
Feb-15-22 08:30AM
Jan-20-22 08:30AM
Jan-04-22 08:30AM
05:07AM
Dec-13-21 04:20PM
Dec-06-21 09:20AM
Nov-05-21 08:24AM
Oct-20-21 10:25AM
Sep-13-21 04:00PM
Sep-06-21 03:00PM
07:09AM
Sep-02-21 04:30PM
Jul-26-21 08:30AM
Jul-22-21 08:00AM
Jul-14-21 08:30AM
Jul-08-21 03:06AM
Jun-15-21 09:00AM
Apr-29-21 03:31AM
Apr-16-21 12:00PM
Mar-16-21 10:52AM
Mar-15-21 02:13AM
(Simply Wall St.) +15.31%
Mar-11-21 04:00PM
02:30PM
Mar-05-21 08:30AM
Mar-04-21 12:30PM
Feb-22-21 09:00AM
Jan-29-21 12:24AM
Jan-19-21 09:00AM
Jan-05-21 08:30AM
Dec-15-20 12:22AM
Dec-14-20 04:00PM
Dec-07-20 04:00PM
Nov-16-20 04:40PM
Nov-11-20 09:00AM
Oct-31-20 10:08AM
Sep-16-20 07:27AM
Sep-14-20 04:00PM
Sep-08-20 04:30PM
Jul-30-20 07:21AM
Jul-27-20 04:01PM
Jul-22-20 08:00AM
Jul-15-20 03:55PM
Jun-17-20 09:37AM
May-27-20 07:05AM
Apr-28-20 09:50AM
Apr-27-20 07:20AM
Mar-28-20 09:23AM
Mar-16-20 09:35AM
Mar-12-20 04:17PM
(ACCESSWIRE) -12.71%
+36.75%
Mar-10-20 08:30AM
Feb-26-20 09:32AM
Feb-18-20 05:44AM
Feb-05-20 09:23AM
Jan-29-20 09:00AM
Jan-17-20 09:34AM
Jan-13-20 06:07AM
Dec-24-19 09:37AM
Champions Oncology, Inc. engages in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. Its technology platform, TumorGraft, is a novel approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company was founded by James M. Martell and David Sidransky on June 4, 1985 and is headquartered in Hackensack, NJ.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Mendelson Daniel Newman Director Jan 12 '24 Buy 6.50 1,000 6,500 198,625 Jan 16 11:45 AM Mendelson Daniel Newman Director Jan 11 '24 Buy 6.27 2,000 12,540 197,625 Jan 12 12:47 PM Mendelson Daniel Newman Director Jan 10 '24 Buy 6.31 2,944 18,577 195,625 Jan 11 10:57 AM Mendelson Daniel Newman Director Jan 09 '24 Buy 6.25 3,000 18,750 192,681 Jan 10 08:57 AM Mendelson Daniel Newman Director Jan 08 '24 Buy 6.15 1,000 6,150 189,681 Jan 09 09:08 AM Mendelson Daniel Newman Director Jan 05 '24 Buy 6.09 2,000 12,180 188,681 Jan 08 03:11 PM Mendelson Daniel Newman Director Jan 04 '24 Buy 6.12 3,000 18,360 186,681 Jan 08 02:54 PM ACKERMAN JOEL Director Oct 17 '23 Option Exercise 2.10 114,552 240,559 856,997 Jan 05 03:52 PM Mendelson Daniel Newman Director Jan 03 '24 Buy 5.83 500 2,915 183,681 Jan 04 01:37 PM Mendelson Daniel Newman Director Dec 21 '23 Buy 4.92 2,500 12,300 183,181 Dec 26 11:48 AM Mendelson Daniel Newman Director Dec 20 '23 Buy 4.82 2,100 10,122 180,681 Dec 21 02:31 PM Mendelson Daniel Newman Director Dec 19 '23 Buy 4.75 5,000 23,750 178,581 Dec 20 09:48 AM Mendelson Daniel Newman Director Sep 29 '23 Buy 6.16 4,000 24,640 173,581 Oct 16 09:53 AM Mendelson Daniel Newman Director Oct 11 '23 Buy 6.40 5,000 32,000 163,081 Oct 13 12:48 PM Mendelson Daniel Newman Director Oct 10 '23 Buy 6.41 1,100 7,051 158,081 Oct 11 09:45 AM Mendelson Daniel Newman Director Oct 06 '23 Buy 6.48 1,530 9,914 156,981 Oct 10 10:02 AM Mendelson Daniel Newman Director Oct 05 '23 Buy 6.47 2,000 12,940 155,451 Oct 06 07:10 AM Mendelson Daniel Newman Director Oct 03 '23 Buy 6.30 2,500 15,750 148,451 Oct 04 05:31 PM Mendelson Daniel Newman Director Oct 04 '23 Buy 6.40 5,000 32,000 153,451 Oct 04 05:30 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite